CEACAM8 and squamous cell carcinoma: Differential outcome of CD66b+ TAN presence according to histological subtypes could be expected since squamous cell carcinoma (SCC) and adenocarcinoma (ADC) are recognized as different diseases regarding biology, treatment stratification and efficacy [23].